ALDAMA PHARMACEUTICALS, INC.
Live / Applied — Response to non-final action entered (as of 12 Feb 2026)
What this means for you
Not registered yet, but its 03 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99266049
- Mark type
- Design + words
- Filed
- 03 Jul 2025
- Attorney of record
- Eric T. Fingerhut
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements; Pharmaceutical preparations for the treatment of a wide variety of diseases, conditions and disorders, namely, infectious diseases; cardiovascular diseases; respiratory diseases; gastrointestinal diseases; metabolic and endocrine disorders; neurological diseases and disorders; psychiatric and mental health disorders; autoimmune and inflammatory diseases; musculoskeletal disorders; dermatological diseases; oncological diseases; hematological disorders; renal and urological diseases; hepatic diseases; ophthalmic diseases; otic diseases; allergic diseases; immunological disorders; pain and pain related conditions; sleep disorders; reproductive and sexual health disorders; hormonal disorders; nutritional deficiencies; genetic disorders; and chronic and acute medical conditions
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
Owner
- Aldama Pharmaceuticals, Inc., Miami, FL, US
Prosecution history
- 12 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Feb 2026 — NON-FINAL ACTION E-MAILED
- 12 Feb 2026 — NON-FINAL ACTION WRITTEN
- 21 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 21 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 21 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 08 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Dec 2025 — NON-FINAL ACTION E-MAILED